Loading...

June Chan, DSc

TitleProfessor
SchoolUCSF School of Medicine
DepartmentEpidemiology & Biostatistics
Address1450 Third St
San Francisco CA 94158
Phone415-514-4923
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard CollegeAB1994Applied Math in Biology
    Harvard School of Public HealthScD1998Epidemiology
    Harvard School of Public HealthPost-doctoral Fellowship2000 Epidemiology
    Collapse Awards and Honors
    Dept. of Urology, UCSF2009Steven & Christine Burd-Safeway Distinguished Professorship
    American Association for Cancer Research & CA Dept. of Health Services2002  - 2003Early Career Investigator Award
    Prostate Cancer Foundation (formerly CaPCURE)1998  - 2000Young Investigator Award
    Society for Epidemiologic Research1998Abraham Lilienfeld Student Prize
    Harvard University1996  - 1997Pforzheimer Public Service Fellowship
    Uppsala University, Sweden1994  - 1995Fulbright Scholar

    Collapse Overview 
    Collapse Overview
    Dr. June M. Chan has broad interests in cancer prevention and public health, in particular what individuals can do to modify their risk of chronic disease, co-morbidity, and death. She has expertise and interests in epidemiology and medical education; and has conducted research on diabetes, pancreatic, colon, and prostate cancer.

    Her current research is focused on understanding how diet, exercise, other lifestyle factors and genetics contribute to prostate cancer progression, aggressiveness, and death. She is particularly interested in identifying modifiable lifestyle risk factors for prostate cancer progression, and using this information to better understand prostate cancer biology & inform public health recommendations. She has worked in this area for ~20 years and was awarded the Steven & Christine Burd-Safeway Distinguished Professorship at UCSF (University of California San Francisco) in 2009 in recognition of her teaching, research, and service activities in the field of prostate cancer. Her team's clinical and translational research studies aim to identify risk-reduction strategies for men with or at high risk for prostate cancer; evaluate novel molecular markers of prostate cancer aggressiveness that may improve screening, diagnosis, or prognosis of clinically relevant disease; and improve cancer survivorship for the millions of men living with prostate cancer worldwide.

    She is PI of a randomized clinical trial examining an exercise intervention among men pursuing active surveillance for prostate cancer; co-PI on a large Dept. of Defense Translational Impact Award focused on improving risk stratification and decision support for men considering active surveillance for low risk prostate cancer; co-lead for a national web-based intervention to promote healthy diet & exercise habits among men living with prostate cancer; and site co-PI for a global clinical trial of exercise among men with metastatic prostate cancer. She serves as mentor for two junior faculty on three distinct lifestyle intervention trials for cancer survivors. She developed the Diet & Lifestyle sub-study with the Cancer of the Prostate Strategic Research Endeavor (CaPSURE); and has collaborated broadly on other studies focused on prostate cancer, including the Health Professionals Follow-up Study, the Selenium and Vitamin E Cancer Prevention Trial (SELECT), the Prostate Cancer Active Surveillance Study (PASS), and the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group.

    Prior Training:
    1994 AB Applied Mathematics in Biology, Harvard College
    1994-95 Fulbright Scholar, Cancer Epidemiology Unit, Uppsala University, Sweden
    1998 ScD Epidemiology, Harvard School of Public Health

    Research Interest Keywords:
    - prostate cancer, cancer prevention, lifestyle risk factors, diet, physical activity, exercise, biomarkers, genetics, epidemiology, medical education, prognostication, public health, risk communication, health education & promotion, pancreatic cancer

    Teaching
    - Steering Committee Member, PhD Program in Epidemiology and Translational Science, UCSF

    - Previously (2007-2015) - Co-Director, Mechanisms, Methods, & Malignancy (M3), Essential Core Curriculum for Medical Students & Discipline Leader, Epidemiology and Evidence-Based Medicine, Essential Core Curriculum for Medical Students

    University Service
    - Executive Committee Member, Department of Epidemiology & Biostatistics, UCSF
    - Co-Director, Urologic Clinical and Translational Science Program, Dept. of Urology, UCSF
    - Member, UCSF Helen Diller Family Comprehensive Cancer Center Prostate Cancer Program Leadership Committee


    Collapse Research 
    Collapse Research Activities and Funding
    Effect of Aerobic Exercise on Genomic Signatures of Prostate Cancer Prognosis
    NIH/NCI R01CA181802Apr 14, 2014 - Feb 28, 2020
    Role: Principal Investigator
    Prostate Microenvironmental &Prostate Cancer Progression
    NIH/NCI R01CA106947Sep 1, 2006 - Aug 31, 2011
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Clinical Trials
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cooperberg MR, Chan J. Epidemiology of prostate cancer. World J Urol. 2017 Jun; 35(6):849. PMID: 28509969.
      View in: PubMed
    2. Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan J. The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study. JMIR Cancer. 2017 Apr 18; 3(1):e5. PMID: 28420602.
      View in: PubMed
    3. Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan J, Witte JS, Simko JP. Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy. Prostate. 2016 Nov 30. PMID: 27900799.
      View in: PubMed
    4. Peisch SF, Van Blarigan EL, Chan J, Stampfer MJ, Kenfield SA. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2016 Aug 12. PMID: 27518576.
      View in: PubMed
    5. Fu PL, Bradley KL, Viswanathan S, Chan J, Stampfer M. Trends in Biometric Health Indices Within an Employer-Sponsored Wellness Program With Outcome-Based Incentives. Am J Health Promot. 2016 Jul; 30(6):453-7. PMID: 27445326.
      View in: PubMed
    6. Chan J, Darke AK, Penney KL, Tangen CM, Goodman PJ, Lee GS, Sun T, Peisch S, Tinianow AM, Rae JM, Klein EA, Thompson IM, Kantoff PW, Mucci LA. Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT. Cancer Epidemiol Biomarkers Prev. 2016 Jul; 25(7):1050-8. PMID: 27197287.
      View in: PubMed
    7. Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LL, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan J, Simko JP. Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens. J Mol Diagn. 2016 May; 18(3):395-406. PMID: 26945428.
      View in: PubMed
    8. Travis RC, Appleby PN, Martin RM, Holly JM, Albanes D, Black A, Bueno-de-Mesquita HB, Chan J, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JA, Kaaks R, Kubo T, Le Marchand L, Metter EJ, Mikami K, Morris JK, Neal DE, Neuhouser ML, Ozasa K, Palli D, Platz EA, Pollak MN, Price AJ, Roobol M, Schaefer C, Schenk JM, Severi G, Stampfer MJ, Stattin P, Tamakoshi A, Tangen CM, Touvier M, Wald NJ, Weiss NS, Zeigler RG, Key TJ, Allen NE. A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk. Cancer Res. 2016 Apr 15; 76(8):2288-300. PMID: 26921328.
      View in: PubMed
    9. Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan J, Febbo PG, Carroll PR, Cullen J, Lawrence HJ. Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score. Urology. 2016 Mar; 89:69-75. PMID: 26723180.
      View in: PubMed
    10. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan J, Paris PL. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. PMID: 26585352.
      View in: PubMed
    11. Kenfield SA, Batista JL, Jahn JL, Downer MK, Van Blarigan EL, Sesso HD, Giovannucci EL, Stampfer MJ, Chan J. Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer. J Natl Cancer Inst. 2016 Mar; 108(3). PMID: 26577654.
      View in: PubMed
    12. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015 Nov 5; 163(4):1011-25. PMID: 26544944.
      View in: PubMed
    13. Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan J, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman GE, Goodman PJ, Gunter MJ, Hamdy FC, Heliövaara M, Helzlsouer KJ, Henderson BE, Hercberg S, Hoffman-Bolton J, Hoover RN, Johansson M, Khaw KT, King IB, Knekt P, Kolonel LN, Le Marchand L, Männistö S, Martin RM, Meyer HE, Mondul AM, Moy KA, Neal DE, Neuhouser ML, Palli D, Platz EA, Pouchieu C, Rissanen H, Schenk JM, Severi G, Stampfer MJ, Tjønneland A, Touvier M, Trichopoulou A, Weinstein SJ, Ziegler RG, Zhou CK, Allen NE. Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies. Am J Clin Nutr. 2015 Nov; 102(5):1142-57. PMID: 26447150; PMCID: PMC4625592 [Available on 11/01/16].
    14. Van Blarigan EL, Gerstenberger JP, Kenfield SA, Giovannucci EL, Stampfer MJ, Jones LW, Clinton SK, Chan J, Mucci LA. Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study. Cancer Prev Res (Phila). 2015 Oct; 8(10):962-7. PMID: 26276753; PMCID: PMC4596787 [Available on 10/01/16].
    15. Chan J, Kenfield SA, Paciorek A, Platz EA, Giovannucci EL, Stampfer MJ. Postdiagnostic Statin Use and the Risk of Lethal Prostate Cancer in the Health Professionals Follow-up Study. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1638-40. PMID: 26189767.
      View in: PubMed
    16. Van Blarigan EL, Kenfield SA, Yang M, Sesso HD, Ma J, Stampfer MJ, Chan J, Chavarro JE. Fat intake after prostate cancer diagnosis and mortality in the Physicians' Health Study. Cancer Causes Control. 2015 Aug; 26(8):1117-26. PMID: 26047644; PMCID: PMC4499006 [Available on 08/01/16].
    17. Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan J, Simko JP, Carroll PR. Patterns of Local Failure following Radiation Therapy for Prostate Cancer. J Urol. 2015 Oct; 194(4):977-82. PMID: 25983194.
      View in: PubMed
    18. Phillips SM, Stampfer MJ, Chan J, Giovannucci EL, Kenfield SA. Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study. J Cancer Surviv. 2015 Sep; 9(3):500-11. PMID: 25876555; PMCID: PMC4537833 [Available on 09/01/16].
    19. Garcia-Albeniz X, Chan J, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer. 2015 May; 51(7):817-24. PMID: 25794605; PMCID: PMC4402138 [Available on 05/01/16].
    20. Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, Jeong S, Fontham ET, Smith G, Mohler JL, Berndt SI, McDonnell SK, Kittles R, Rybicki BA, Freedman M, Kantoff PW, Pomerantz M, Breyer JP, Smith JR, Rebbeck TR, Mercola D, Isaacs WB, Wiklund F, Cussenot O, Thibodeau SN, Schaid DJ, Cannon-Albright L, Cooney KA, Chanock SJ, Stanford JL, Chan J, Witte J, Xu J, Bensen JT, Taylor JA, Catalona WJ. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet. 2015 Apr; 134(4):439-50. PMID: 25715684; PMCID: PMC4586077 [Available on 04/01/16].
    21. Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan J, Kantoff PW, Stampfer MJ, Nguyen PL, Mucci LA. GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis. Clin Genitourin Cancer. 2015 Aug; 13(4):370-377.e1. PMID: 25662905.
      View in: PubMed
    22. Ryan CJ, Chan J. Hair, hormones, and high-risk prostate cancer. J Clin Oncol. 2015 Feb 10; 33(5):386-7. PMID: 25547509.
      View in: PubMed
    23. Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, L Giovannucci E, Chan J. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2015 Jan; 107(1):360. PMID: 25505227; PMCID: PMC4296194 [Available on 01/01/16].
    24. Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan J. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2015 Jan; 75(1):60-9. PMID: 25284284; PMCID: PMC4257852 [Available on 01/01/16].
    25. Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan J, Meng MV, Simko JP, Cooperberg MR, Carroll PR. Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer. J Urol. 2015 Mar; 193(3):807-11. PMID: 25261803.
      View in: PubMed
    26. Punnen S, Cowan JE, Chan J, Carroll PR, Cooperberg MR. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry. Eur Urol. 2015 Oct; 68(4):600-8. PMID: 25242555.
      View in: PubMed
    27. Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan J, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014 Sep; 66(3):550-60. PMID: 24836057.
      View in: PubMed
    28. Chan J, Van Blarigan EL, Kenfield SA. What should we tell prostate cancer patients about (secondary) prevention? Curr Opin Urol. 2014 May; 24(3):318-23. PMID: 24625429; PMCID: PMC4084902.
    29. Van Blarigan EL, Ma J, Kenfield SA, Stampfer MJ, Sesso HD, Giovannucci EL, Witte JS, Erdman JW, Chan J, Penney KL. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival. Cancer Epidemiol Biomarkers Prev. 2014 Jun; 23(6):1037-46. PMID: 24711484; PMCID: PMC4047147.
    30. Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan J. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control. 2014 Apr; 25(4):515-23. PMID: 24504435; PMCID: PMC3990413.
    31. Jones LW, Hornsby WE, Freedland SJ, Lane A, West MJ, Moul JW, Ferrandino MN, Allen JD, Kenjale AA, Thomas SM, Herndon JE, Koontz BF, Chan J, Khouri MG, Douglas PS, Eves ND. Effects of nonlinear aerobic training on erectile dysfunction and cardiovascular function following radical prostatectomy for clinically localized prostate cancer. Eur Urol. 2014 May; 65(5):852-5. PMID: 24315706; PMCID: PMC4089506.
    32. Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan J. Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™. J Urol. 2014 Apr; 191(4):971-6. PMID: 24095905.
      View in: PubMed
    33. Ornish D, Lin J, Chan J, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJ, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol. 2013 Oct; 14(11):1112-20. PMID: 24051140.
      View in: PubMed
    34. Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan J, Meng MV, Carroll PR. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies. Eur Urol. 2014 Aug; 66(2):337-42. PMID: 24035632.
      View in: PubMed
    35. Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan J. Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence. Prostate. 2013 Dec; 73(16):1786-95. PMID: 24038157.
      View in: PubMed
    36. Kenfield SA, DuPre N, Richman EL, Stampfer MJ, Chan J, Giovannucci EL. Mediterranean diet and prostate cancer risk and mortality in the Health Professionals Follow-up Study. Eur Urol. 2014 May; 65(5):887-94. PMID: 23962747; PMCID: PMC4157361.
    37. Richman EL, Kenfield SA, Chavarro JE, Stampfer MJ, Giovannucci EL, Willett WC, Chan J. Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality. JAMA Intern Med. 2013 Jul 22; 173(14):1318-26. PMID: 23752662; PMCID: PMC3935610.
    38. Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan J, Carroll PR. Active surveillance: does serial prostate biopsy increase histological inflammation? Prostate Cancer Prostatic Dis. 2013 Jun; 16(2):165-9. PMID: 23318528.
      View in: PubMed
    39. Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, Carroll PR, Chan J, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, Feng Z, True LD, Brooks JD. A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray. Adv Anat Pathol. 2013 Jan; 20(1):39-44. PMID: 23232570; PMCID: PMC3535290.
    40. Chan J, Gong Z, Holly EA, Bracci PM. Dietary patterns and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Nutr Cancer. 2013; 65(1):157-64. PMID: 23368926; PMCID: PMC4465200.
    41. Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan J. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prev Res (Phila). 2012 Oct; 5(10):1223-8. PMID: 22961777; PMCID: PMC3526345.
    42. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC, Chan J. Choline intake and risk of lethal prostate cancer: incidence and survival. Am J Clin Nutr. 2012 Oct; 96(4):855-63. PMID: 22952174; PMCID: PMC3441112.
    43. Choe KS, Cowan JE, Chan J, Carroll PR, D'Amico AV, Liauw SL. Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy. J Clin Oncol. 2012 Oct 1; 30(28):3540-4. PMID: 22927523; PMCID: PMC3454771.
    44. Chan J, Litwack-Harrison S, Bauer SR, Daniels NA, Wilt TJ, Shannon J, Bauer DC. Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1886-8. PMID: 22879205; PMCID: PMC3489270.
    45. Cooperberg MR, Chan J. Editorial comment. Urology. 2012 Aug; 80(2):305-6. PMID: 22749427.
      View in: PubMed
    46. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan J. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):211. PMID: 22588589.
      View in: PubMed
    47. Richman EL, Chan J. Selenium and prostate cancer: the puzzle isn't finished yet. Am J Clin Nutr. 2012 Jul; 96(1):1-2. PMID: 22623750; PMCID: PMC3374730.
    48. Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK. Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid. Clin Cancer Res. 2012 Jun 15; 18(12):3250-60. PMID: 22553345.
      View in: PubMed
    49. Pettersson A, Kasperzyk JL, Kenfield SA, Richman EL, Chan J, Willett WC, Stampfer MJ, Mucci LA, Giovannucci EL. Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death. Cancer Epidemiol Biomarkers Prev. 2012 Mar; 21(3):428-36. PMID: 22315365; PMCID: PMC3297731.
    50. Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan J. PSA screening: determinants of primary-care physician practice patterns. Prostate Cancer Prostatic Dis. 2012 Jun; 15(2):189-94. PMID: 22343837.
      View in: PubMed
    51. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan J. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila). 2011 Dec; 4(12):2110-21. PMID: 21930800; PMCID: PMC3232297.
    52. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan J. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. PMID: 21912659; PMCID: PMC3164676.
    53. Richman EL, Carroll PR, Chan J. Vegetable and fruit intake after diagnosis and risk of prostate cancer progression. Int J Cancer. 2012 Jul 1; 131(1):201-10. PMID: 21823116; PMCID: PMC3310254.
    54. Kenfield SA, Stampfer MJ, Chan J, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA. 2011 Jun 22; 305(24):2548-55. PMID: 21693743; PMCID: PMC3562349.
    55. Aggarwal RR, Ryan CJ, Chan J. Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? Urol Oncol. 2013 Jul; 31(5):522-30. PMID: 21658978.
      View in: PubMed
    56. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan J. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 1; 71(11):3889-95. PMID: 21610110; PMCID: PMC3107352.
    57. Kenfield SA, Stampfer MJ, Giovannucci E, Chan J. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011 Feb 20; 29(6):726-32. PMID: 21205749; PMCID: PMC3056656.
    58. Abe M, Xie W, Regan MM, King IB, Stampfer MJ, Kantoff PW, Oh WK, Chan J. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU Int. 2011 Jan; 107(1):126-34. PMID: 20477822; PMCID: PMC3010266.
    59. Chan J, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control. 2011 Jan; 22(1):141-50. PMID: 21103921; PMCID: PMC3002170.
    60. Gong Z, Holly EA, Wang F, Chan J, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int J Cancer. 2010 Oct 15; 127(8):1893-904. PMID: 20104522; PMCID: PMC2930138.
    61. Katz MS, Carroll PR, Cowan JE, Chan J, D'Amico AV. Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE. BJU Int. 2010 Sep; 106(5):627-32. PMID: 20151961.
      View in: PubMed
    62. Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan J. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians. Urol Oncol. 2012 Mar-Apr; 30(2):155-60. PMID: 20800514.
      View in: PubMed
    63. Walsh TJ, Schembri M, Turek PJ, Chan J, Carroll PR, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010 May 1; 116(9):2140-7. PMID: 20309846; PMCID: PMC2893877.
    64. Barnett CM, Nielson CM, Shannon J, Chan J, Shikany JM, Bauer DC, Hoffman AR, Barrett-Connor E, Orwoll E, Beer TM. Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men. Cancer Causes Control. 2010 Aug; 21(8):1297-303. PMID: 20383574; PMCID: PMC2903686.
    65. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan J. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010 Mar; 91(3):712-21. PMID: 20042525; PMCID: PMC3132069.
    66. Shappley WV, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG, Chan J. Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort. J Clin Oncol. 2009 Oct 20; 27(30):4980-5. PMID: 19720918; PMCID: PMC2799054.
    67. Chan J, Oh WK, Xie W, Regan MM, Stampfer MJ, King IB, Abe M, Kantoff PW. Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer. J Clin Oncol. 2009 Aug 1; 27(22):3577-83. PMID: 19528373; PMCID: PMC2720077.
    68. Chan J, Wang F, Holly EA. Sweets, sweetened beverages, and risk of pancreatic cancer in a large population-based case-control study. Cancer Causes Control. 2009 Aug; 20(6):835-46. PMID: 19277880; PMCID: PMC2694313.
    69. Walsh TJ, Croughan MS, Schembri M, Chan J, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med. 2009 Feb 23; 169(4):351-6. PMID: 19237718; PMCID: PMC2881689.
    70. Farhat GN, Taioli E, Cauley JA, Zmuda JM, Orwoll E, Bauer DC, Wilt TJ, Hoffman AR, Beer TM, Shikany JM, Daniels N, Chan J, Fink HA, Barrett-Connor E, Parsons JK, Bunker CH. The association of bone mineral density with prostate cancer risk in the Osteoporotic Fractures in Men (MrOS) Study. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):148-54. PMID: 19124492; PMCID: PMC2651680.
    71. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey JV, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schröder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan J, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med. 2008 Oct 7; 149(7):461-71, W83-8. PMID: 18838726; PMCID: PMC2584869.
    72. Fall K, Stark JR, Mucci LA, Chan J, Stampfer MJ, Kurth T, Febbo PG, Kantoff P, Ma J. No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk. Prostate. 2008 Sep 15; 68(13):1416-20. PMID: 18615538; PMCID: PMC2958090.
    73. Dall'Era MA, Cooperberg MR, Chan J, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008 Apr 15; 112(8):1650-9. PMID: 18306379.
      View in: PubMed
    74. Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst. 2008 Feb 6; 100(3):170-83. PMID: 18230794.
      View in: PubMed
    75. Chan J, Wang F, Holly EA. Whole grains and risk of pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area, California. Am J Epidemiol. 2007 Nov 15; 166(10):1174-85. PMID: 17881383.
      View in: PubMed
    76. Chan J, Wang F, Holly EA. Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California. Cancer Causes Control. 2007 Dec; 18(10):1153-67. PMID: 17805983.
      View in: PubMed
    77. Keating GA, Bogen KT, Chan J. Development of a meat frequency questionnaire for use in diet and cancer studies. J Am Diet Assoc. 2007 Aug; 107(8):1356-62. PMID: 17659903.
      View in: PubMed
    78. Kenfield SA, Chang ST, Chan J. Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer. Curr Treat Options Oncol. 2007 Jun; 8(3):173-96. PMID: 17763836.
      View in: PubMed
    79. Penson DF, Chan J. Prostate cancer. J Urol. 2007 Jun; 177(6):2020-9. PMID: 17509282.
      View in: PubMed
    80. Shannon J, Shikany JM, Barrett-Connor E, Marshall LM, Bunker CH, Chan J, Stone KL, Orwoll E. Demographic factors associated with the diet quality of older US men: baseline data from the Osteoporotic Fractures in Men (MrOS) study. Public Health Nutr. 2007 Aug; 10(8):810-8. PMID: 17381915.
      View in: PubMed
    81. Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan J, Weinberg V, Small EJ, Goldfine ID. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Urol Oncol. 2007 Mar-Apr; 25(2):134-40. PMID: 17349528.
      View in: PubMed
    82. Bogen KT, Keating GA, Chan J, Paine LJ, Simms EL, Nelson DO, Holly EA. Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans. Prostate Cancer Prostatic Dis. 2007; 10(3):261-9. PMID: 17224912.
      View in: PubMed
    83. Latini DM, Chan J, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE. Urology. 2006 Dec; 68(6):1242-7. PMID: 17141841.
      View in: PubMed
    84. Chan J, Feraco A, Shuman M, Hernández-Díaz S. The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs. Hematol Oncol Clin North Am. 2006 Aug; 20(4):797-809. PMID: 16861115.
      View in: PubMed
    85. Chan J, Holick CN, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Giovannucci EL. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control. 2006 Mar; 17(2):199-208. PMID: 16425098.
      View in: PubMed
    86. Chan J, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005 Dec; 66(6):1223-8. PMID: 16360447.
      View in: PubMed
    87. Chan J, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005 Nov 10; 23(32):8152-60. PMID: 16278466.
      View in: PubMed
    88. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan J, Anast JW, Carroll PR, Kane CJ. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov; 66(5):1060-5. PMID: 16286124.
      View in: PubMed
    89. Chan J, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev. 2005 Sep; 14(9):2093-7. PMID: 16172215.
      View in: PubMed
    90. Chan J, Latini DM, Cowan J, Duchane J, Carroll PR. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control. 2005 Sep; 16(7):789-97. PMID: 16132789.
      View in: PubMed
    91. Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan J, Cooperberg MR, Carroll PR, Kane CJ. The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE). J Urol. 2005 Apr; 173(4):1132-8. PMID: 15758721.
      View in: PubMed
    92. Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan J, Yuan J, Harris CC, Bowman ED, Clayman GL, Lippman SM, Lee JJ, Zheng W, Balmain A. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 2005 Aug; 26(8):1368-73. PMID: 15802297.
      View in: PubMed
    93. Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan J, Carroll PR. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE. J Urol. 2005 Mar; 173(3):732-6. PMID: 15711258.
      View in: PubMed
    94. Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll PR, Chan J. Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer. Clin Prostate Cancer. 2005 Mar; 3(4):239-45. PMID: 15882480.
      View in: PubMed
    95. Carroll PR, Chan J, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW. Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment. J Urol. 2004 Nov; 172(5 Pt 2):S3-5. PMID: 15535434.
      View in: PubMed
    96. Chan J, Jou RM, Carroll PR. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004 Nov; 172(5 Pt 2):S13-6; discussion S17. PMID: 15535436.
      View in: PubMed
    97. Ewart-Toland A, Chan J, Yuan J, Balmain A, Ma J. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):759-64. PMID: 15159307.
      View in: PubMed
    98. Wu K, Willett WC, Chan J, Fuchs CS, Colditz GA, Rimm EB, Giovannucci EL. A prospective study on supplemental vitamin e intake and risk of colon cancer in women and men. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1298-304. PMID: 12433706.
      View in: PubMed
    99. Leitzmann MF, Stampfer MJ, Ma J, Chan J, Colditz GA, Willett WC, Giovannucci E. Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1108-11. PMID: 12376516.
      View in: PubMed
    100. Chan J, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst. 2002 Jul 17; 94(14):1099-106. PMID: 12122101.
      View in: PubMed
    101. Chan J, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr. 2001 Oct; 74(4):549-54. PMID: 11566656.
      View in: PubMed
    102. Ma J, Giovannucci E, Pollak M, Chan J, Gaziano JM, Willett W, Stampfer MJ. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst. 2001 Sep 5; 93(17):1330-6. PMID: 11535708.
      View in: PubMed
    103. Chan J, Giovannucci EL. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev. 2001; 23(1):82-6. PMID: 11588858.
      View in: PubMed
    104. Chan J, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev. 2001; 23(1):87-92. PMID: 11588859.
      View in: PubMed
    105. Chan J, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, Virtamo J. Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland). Cancer Causes Control. 2000 Oct; 11(9):859-67. PMID: 11075876.
      View in: PubMed
    106. Chan J, Stampfer MJ, Giovannucci E, Ma J, Pollak M. Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S32-3. PMID: 10984284.
      View in: PubMed
    107. Ma J, Pollak M, Giovannucci E, Chan J, Tao Y, Hennekens C, Stampfer MJ. A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S28-9. PMID: 10984282.
      View in: PubMed
    108. Chan J, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev. 1999 Oct; 8(10):893-9. PMID: 10548318.
      View in: PubMed
    109. Ma J, Pollak MN, Giovannucci E, Chan J, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999 Apr 7; 91(7):620-5. PMID: 10203281.
      View in: PubMed
    110. Lindblad P, Chow WH, Chan J, Bergström A, Wolk A, Gridley G, McLaughlin JK, Nyrén O, Adami HO. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia. 1999 Jan; 42(1):107-12. PMID: 10027588.
      View in: PubMed
    111. Chan J, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk A. Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden) Cancer Causes Control. 1998 Dec; 9(6):559-66. PMID: 10189041.
      View in: PubMed
    112. Chan J, Stampfer MJ, Giovannucci EL. What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol. 1998 Aug; 8(4):263-73. PMID: 9870033.
      View in: PubMed
    113. Chan J, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998 Jan 23; 279(5350):563-6. PMID: 9438850.
      View in: PubMed
    114. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995 Mar 4; 310(6979):555-9. PMID: 7888928; PMCID: PMC2548937.
    115. Chan J, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994 Sep; 17(9):961-9. PMID: 7988316.
      View in: PubMed
    June's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP